MERS-CoV spike protein: Targets for vaccines and therapeutics (Q30248743)

13 June 2017

3 references

13 July 2022

22 October 2022

MERS-CoV spike protein: Targets for vaccines and therapeutics (English)

1 reference

27468951

Middle East respiratory syndrome coronavirus

13 June 2017

main subject

0 references

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27468951%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

4

Jinghua Yan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27468951%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

3

Guangwen Lu

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27468951%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

author name string

Gary Wong

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27468951%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

George F Gao

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27468951%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

language of work or name

1 reference

25 July 2016

1 reference

27468951

13 June 2017

1 September 2016

2 references

13 July 2022

22 October 2022

3 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27468951%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

13 July 2022

22 October 2022

133

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27468951%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

page(s)

165-177

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27468951%20AND%20SRC:MED&resulttype=core&format=json

Coronavirus avian infectious bronchitis virus

11 June 2020

cites work

1 reference

12 December 2020

Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques

1 reference

12 December 2020

Coronavirus 229E-related pneumonia in immunocompromised patients

1 reference

12 December 2020

Structure of the Fusion Core and Inhibition of Fusion by a Heptad Repeat Peptide Derived from the S Protein of Middle East Respiratory Syndrome Coronavirus

1 reference

12 December 2020

MERS coronavirus in dromedary camel herd, Saudi Arabia

1 reference

12 December 2020

Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp

1 reference

12 December 2020

Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group

1 reference

12 December 2020

Potent antibody therapeutics by design

1 reference

12 December 2020

Antiviral drugs specific for coronaviruses in preclinical development

1 reference

12 December 2020

Coronavirus infections in working adults. Eight-year study with 229 E and OC 43

1 reference

12 December 2020

Multi-Organ Damage in Human Dipeptidyl Peptidase 4 Transgenic Mice Infected with Middle East Respiratory Syndrome-Coronavirus

1 reference

12 December 2020

MF59-adjuvanted vaccines: increased immunogenicity with an optimal safety profile

1 reference

12 December 2020

Intranasal vaccination with recombinant receptor-binding domain of MERS-CoV spike protein induces much stronger local mucosal immune responses than subcutaneous immunization: Implication for designing novel mucosal MERS vaccines.

1 reference

12 December 2020

Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor

1 reference

12 December 2020

Both heptad repeats of human respiratory syncytial virus fusion protein are potent inhibitors of viral fusion

1 reference

12 December 2020

Proteolytic activation of the SARS-coronavirus spike protein: cutting enzymes at the cutting edge of antiviral research.

1 reference

12 December 2020

A safe and convenient pseudovirus-based inhibition assay to detect neutralizing antibodies and screen for viral entry inhibitors against the novel human coronavirus MERS-CoV

1 reference

12 December 2020

A truncated receptor-binding domain of MERS-CoV spike protein potently inhibits MERS-CoV infection and induces strong neutralizing antibody responses: implication for developing therapeutics and vaccines

1 reference

12 December 2020

Virus membrane-fusion proteins: more than one way to make a hairpin

1 reference

12 December 2020

Characterization and inhibition of SARS-coronavirus main protease

1 reference

12 December 2020

Junctional and allele-specific residues are critical for MERS-CoV neutralization by an exceptionally potent germline-like antibody.

1 reference

12 December 2020

MERS-CoV in Upper Respiratory Tract and Lungs of Dromedary Camels, Saudi Arabia, 2013-2014

1 reference

12 December 2020

The morphology of three previously uncharacterized human respiratory viruses that grow in organ culture.

1 reference

12 December 2020

The structural and accessory proteins M, ORF 4a, ORF 4b, and ORF 5 of Middle East respiratory syndrome coronavirus (MERS-CoV) are potent interferon antagonists

1 reference

12 December 2020

A neutralizing human monoclonal antibody protects african green monkeys from hendra virus challenge

1 reference

12 December 2020

Clinical applications of DNA vaccines: current progress

1 reference

12 December 2020

A neutralizing human monoclonal antibody protects against lethal disease in a new ferret model of acute nipah virus infection

1 reference

12 December 2020

A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein.

1 reference

12 December 2020

Middle East respiratory syndrome coronavirus accessory protein 4a is a type I interferon antagonist

1 reference

12 December 2020

Middle East respiratory syndrome coronavirus spike protein delivered by modified vaccinia virus Ankara efficiently induces virus-neutralizing antibodies

1 reference

12 December 2020

Generation of a transgenic mouse model of Middle East respiratory syndrome coronavirus infection and disease

1 reference

12 December 2020

Middle East respiratory syndrome coronavirus (MERS-CoV) entry inhibitors targeting spike protein.

1 reference

12 December 2020

MERS, SARS, and Ebola: The Role of Super-Spreaders in Infectious Disease

1 reference

12 December 2020

Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26.

1 reference

12 December 2020

Bat origins of MERS-CoV supported by bat coronavirus HKU4 usage of human receptor CD26

1 reference

12 December 2020

Treatment With Lopinavir/Ritonavir or Interferon-β1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset

1 reference

12 December 2020

Potent neutralization of MERS-CoV by human neutralizing monoclonal antibodies to the viral spike glycoprotein

1 reference

12 December 2020

Mice with megabase humanization of their immunoglobulin genes generate antibodies as efficiently as normal mice

1 reference

12 December 2020

SARS: systematic review of treatment effects

1 reference

12 December 2020

Two Mutations Were Critical for Bat-to-Human Transmission of Middle East Respiratory Syndrome Coronavirus

1 reference

12 December 2020

1 reference

12 December 2020

Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia

1 reference

12 December 2020

The spike protein of SARS-CoV--a target for vaccine and therapeutic development

1 reference

12 December 2020

Treatment with interferon-α2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques

1 reference

12 December 2020

Animal models of Middle East respiratory syndrome coronavirus infection

1 reference

12 December 2020

Characterization and Demonstration of the Value of a Lethal Mouse Model of Middle East Respiratory Syndrome Coronavirus Infection and Disease

1 reference

12 December 2020

Evaluation of candidate vaccine approaches for MERS-CoV.

1 reference

12 December 2020

A review of palivizumab and emerging therapies for respiratory syncytial virus

1 reference

12 December 2020

Structure-based identification of small molecule antiviral compounds targeted to the gp41 core structure of the human immunodeficiency virus type 1

1 reference

12 December 2020

Potent neutralization of Hendra and Nipah viruses by human monoclonal antibodies

1 reference

12 December 2020

Identification of a receptor-binding domain in the S protein of the novel human coronavirus Middle East respiratory syndrome coronavirus as an essential target for vaccine development

1 reference

12 December 2020

Alphavirus-based vaccines

1 reference

12 December 2020

Recovery in tracheal organ cultures of novel viruses from patients with respiratory disease

1 reference

12 December 2020

Effect of amino acid replacements, additions and deletions on the antiviral activity of a peptide derived from the HIV-1 GP41 sequence

1 reference

12 December 2020

Prophylaxis With a Middle East Respiratory Syndrome Coronavirus (MERS-CoV)-Specific Human Monoclonal Antibody Protects Rabbits From MERS-CoV Infection

1 reference

12 December 2020

3-Hydroxyphthalic anhydride-modified human serum albumin as a microbicide candidate inhibits HIV infection by blocking viral entry

1 reference

12 December 2020

Identification of an ideal adjuvant for receptor-binding domain-based subunit vaccines against Middle East respiratory syndrome coronavirus.

1 reference

12 December 2020

Trimeric Subdomain of the Simian Immunodeficiency Virus Envelope Glycoprotein

1 reference

12 December 2020

Host cell proteases: Critical determinants of coronavirus tropism and pathogenesis

1 reference

12 December 2020

Chemically modified bovine beta-lactoglobulin inhibits human papillomavirus infection

1 reference

12 December 2020

Therapeutic proteins.

1 reference

12 December 2020

Mechanisms of coronavirus cell entry mediated by the viral spike protein

1 reference

12 December 2020

Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection

1 reference

12 December 2020

Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution

1 reference

12 December 2020

Pre-fusion structure of a human coronavirus spike protein.

1 reference

12 December 2020

Peptide vaccines against cancer, infectious diseases, and conception

1 reference

12 December 2020

High-throughput engineering of the mouse genome coupled with high-resolution expression analysis

1 reference

12 December 2020

Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC

1 reference

12 December 2020

Coronavirus immunogens

1 reference

12 December 2020

Structures and Mechanisms of Viral Membrane Fusion Proteins: Multiple Variations on a Common Theme

1 reference

12 December 2020

Middle East respiratory syndrome: obstacles and prospects for vaccine development

1 reference

12 December 2020

Fusion core structure of the severe acute respiratory syndrome coronavirus (SARS-CoV): in search of potent SARS-CoV entry inhibitors

1 reference

12 December 2020

An animal model of MERS produced by infection of rhesus macaques with MERS coronavirus

1 reference

12 December 2020

DNA vaccines in veterinary use.

1 reference

12 December 2020

Conditionals by inversion provide a universal method for the generation of conditional alleles

1 reference

12 December 2020

Catalytic function and substrate specificity of the papain-like protease domain of nsp3 from the Middle East respiratory syndrome coronavirus

1 reference

12 December 2020

A review of feline infectious peritonitis virus: molecular biology, immunopathogenesis, clinical aspects, and vaccination

1 reference

12 December 2020

Functional importance of the coiled-coil of the Ebola virus glycoprotein

1 reference

12 December 2020

Protective Efficacy of Recombinant Modified Vaccinia Virus Ankara Delivering Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein

1 reference

12 December 2020

Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study

1 reference

12 December 2020

Pneumonia from human coronavirus in a macaque model

1 reference

12 December 2020

Vaccine adjuvants: mode of action

1 reference

12 December 2020

SARS coronavirus accessory proteins.

1 reference

12 December 2020

Protective Effect of Intranasal Regimens Containing Peptidic Middle East Respiratory Syndrome Coronavirus Fusion Inhibitor Against MERS-CoV Infection

1 reference

12 December 2020

Common principles and intermediates of viral protein-mediated fusion: the HIV-1 paradigm

1 reference

12 December 2020

Phase I clinical evaluation of a six-plasmid multiclade HIV-1 DNA candidate vaccine

1 reference

12 December 2020

The "common cold" in frail older persons: impact of rhinovirus and coronavirus in a senior daycare center

1 reference

12 December 2020

Cryo-electron microscopy structure of a coronavirus spike glycoprotein trimer

1 reference

12 December 2020

Human antibody production in transgenic animals

1 reference

12 December 2020

The receptor binding domain of the new Middle East respiratory syndrome coronavirus maps to a 231-residue region in the spike protein that efficiently elicits neutralizing antibodies

1 reference

12 December 2020

Infection with MERS-CoV causes lethal pneumonia in the common marmoset

1 reference

12 December 2020

Six-helix bundle assembly and characterization of heptad repeat regions from the F protein of Newcastle disease virus

1 reference

12 December 2020

Coronavirus infection in intensively managed cattle with respiratory disease.

1 reference

12 December 2020

Structural and genetic basis for development of broadly neutralizing influenza antibodies

1 reference

12 December 2020

The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor

1 reference

12 December 2020

A phase I dose escalation trial of vaccine replicon particles (VRP) expressing prostate-specific membrane antigen (PSMA) in subjects with prostate cancer

1 reference

12 December 2020

Middle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia

1 reference

12 December 2020

Rapid generation of a mouse model for Middle East respiratory syndrome

1 reference

12 December 2020

Coronavirus infection in acute lower respiratory tract disease of infants

1 reference

12 December 2020

Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus

1 reference

12 December 2020

Full-genome deep sequencing and phylogenetic analysis of novel human betacoronavirus

1 reference

12 December 2020

Current advancements and potential strategies in the development of MERS-CoV vaccines

1 reference

12 December 2020

Enterovirus 71 and Coxsackievirus A16 3C Proteases: Binding to Rupintrivir and Their Substrates and Anti-Hand, Foot, and Mouth Disease Virus Drug Design

1 reference

12 December 2020

Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans

1 reference

12 December 2020

Anti-SARS coronavirus agents: a patent review (2008 - present).

1 reference

12 December 2020

Peptide Vaccine: Progress and Challenges

1 reference

12 December 2020

Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012.

1 reference

12 December 2020

Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4

1 reference

12 December 2020

Inhibition of novel β coronavirus replication by a combination of interferon-α2b and ribavirin

1 reference

12 December 2020

Searching for an ideal vaccine candidate among different MERS coronavirus receptor-binding fragments--the importance of immunofocusing in subunit vaccine design

1 reference

12 December 2020

HIV-1 inhibition by a peptide

1 reference

12 December 2020

Bat-to-human: spike features determining 'host jump' of coronaviruses SARS-CoV, MERS-CoV, and beyond

1 reference

12 December 2020

Structure of SARS coronavirus spike receptor-binding domain complexed with receptor

1 reference

12 December 2020

A human T-cell leukemia virus type 1 regulatory element enhances the immunogenicity of human immunodeficiency virus type 1 DNA vaccines in mice and nonhuman primates

1 reference

12 December 2020

Design of Potential RNAi (miRNA and siRNA) Molecules for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Gene Silencing by Computational Method

1 reference

12 December 2020

Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides

1 reference

12 December 2020

Identification of a new human coronavirus

1 reference

12 December 2020

Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia

1 reference

12 December 2020

An overview of successful TGEV vaccination strategies and discussion on the interrelationship between TGEV and PRCV

1 reference

12 December 2020

Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture

1 reference

12 December 2020

Thiopurine analogs and mycophenolic acid synergistically inhibit the papain-like protease of Middle East respiratory syndrome coronavirus

1 reference

12 December 2020

Assessing activity and inhibition of Middle East respiratory syndrome coronavirus papain-like and 3C-like proteases using luciferase-based biosensors

1 reference

12 December 2020

The many mechanisms of viral membrane fusion proteins.

1 reference

12 December 2020

An outbreak of coronavirus OC43 respiratory infection in Normandy, France

1 reference

12 December 2020

A new virus isolated from the human respiratory tract

1 reference

12 December 2020

Antibacterial monoclonal antibodies: the next generation?

1 reference

12 December 2020

A synthetic consensus anti-spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates

1 reference

12 December 2020

MERS in South Korea and China: a potential outbreak threat?

1 reference

12 December 2020

Evidence for camel-to-human transmission of MERS coronavirus

1 reference

12 December 2020

1 reference

12 December 2020

Development of chemical inhibitors of the SARS coronavirus: viral helicase as a potential target

1 reference

12 December 2020

Respiratory coronavirus infections in children younger than two years of age.

1 reference

12 December 2020

Developments in Viral Vector-Based Vaccines

1 reference

12 December 2020

Proteolytic processing, deubiquitinase and interferon antagonist activities of Middle East respiratory syndrome coronavirus papain-like protease

1 reference

12 December 2020

Drug design targeting the main protease, the Achilles' heel of coronaviruses

1 reference

12 December 2020

Recent development of 3C and 3CL protease inhibitors for anti-coronavirus and anti-picornavirus drug discovery

1 reference

12 December 2020

Host cell entry of Middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein

1 reference

12 December 2020

Structural basis for the neutralization of MERS-CoV by a human monoclonal antibody MERS-27

1 reference

12 December 2020

An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels

1 reference

12 December 2020

A Computational Approach for Predicting Role of Human MicroRNAs in MERS-CoV Genome.

1 reference

12 December 2020

Canine viral vaccines at a turning point--a personal perspective

1 reference

12 December 2020

Human infection with MERS coronavirus after exposure to infected camels, Saudi Arabia, 2013.

1 reference

12 December 2020

Clinical development of Modified Vaccinia virus Ankara vaccines

1 reference

12 December 2020

CULTIVATION OF A NOVEL TYPE OF COMMON-COLD VIRUS IN ORGAN CULTURES.

1 reference

12 December 2020

ADS-J1 inhibits human immunodeficiency virus type 1 entry by interacting with the gp41 pocket region and blocking fusion-active gp41 core formation

1 reference

12 December 2020

Phase I safety and immunogenicity evaluations of an alphavirus replicon HIV-1 subtype C gag vaccine in healthy HIV-1-uninfected adults

1 reference

12 December 2020

HIV-1 neutralizing antibodies: understanding nature's pathways

1 reference

12 December 2020

10.1016/J.ANTIVIRAL.2016.07.015

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27468951%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27468951%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

27468951

1 reference